"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Beta Drugs Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs	Chairman : Rahul Batra
Home : Indian Private	Book Value: 139.8706763
BSE Code : 535022	Market Cap: 1082.42
NSE Code : BETA	P / E : 85.77

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Type	3Qtr	2Qtr	1Qtr	4Qtr
Net Sales	50.28	54.48	66.32	53.74
Other Income	2.51	2.74	2.97	3.93
Total Income	52.78	57.22	69.30	57.66
Total Expenditure	43.73	49.75	58.82	50.71
Operating Profit	9.05	7.48	10.48	6.95
Interest	3.17	2.97	2.79	2.81
Gross Profit	5.88	4.50	7.70	4.15
Depreciation	2.51	2.38	2.04	2.14
Tax	0.12	0.61	1.60	0.90
Deferred Tax	0.00	0.00	-0.18	-0.29
Reported Profit After Tax	3.25	1.51	4.23	1.39

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView